X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Rising care costs The back-and-forth between industry groups might obscure a positive trend: data showing U.S. drug price inflation has moderated in recent years. (Image: Shutterstock)

A pharmaceutical industry group is pushing back against a recent report that said some drug price increases were not supported by clinical improvement.

The Nov. 16 report by the Institute for Clinical and Economic Review (ICER) said that among the top 10 drugs with price increases in 2020 that had substantial effects on US spending, seven of 10 drugs did not have new evidence of a new clinical benefit. The report focused on Humira, a rheumatoid arthritis drug—which, by itself, accounted for $1.4 billion of the $1.67 billion in additional drug spending.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

 

BenefitsPRO Broker Expo 2022Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information
 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO
Live Chat

Copyright © 2022 ALM Media Properties, LLC. All Rights Reserved.